510(k) Report

510(k) · Cleared

Cleared

MYAH

K211868510(k) TraditionalCleared Mar 1, 2022258-day reviewClass II21 CFR 886.1850

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Visia Imaging S.R.L. · MXK Device, Analysis, Anterior Segment

Cleared on Mar 1, 2022 after a 258-day review. FDA’s file for it is a 510(k) statement, which names no predicate.

Decided
Mar 1, 2022
Review
258 days
Class
Class II
Product code
MXK
Recalls
None
Predicates
0

FDA’s file for it is a 510(k) statement, which names no predicate.

FIG. 1 — Lineage of K211868Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MXK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MXK device

  1. #1 K251848 Pentacam® Cornea OCTscore 13.7 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All MXK devices

MXK Device, Analysis, Anterior Segment: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · MXK

1in 2025

2007: 12008: 12015: 12016: 12019: 22020: 12021: 12022: 12023: 12024: 12025: 12026 (partial year): 1
2007high 2 (2019) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MXK

Too few MXK 510(k)s in any year since 2007 to give a median.

Recalls per year · MXK

1in 2017

2017: 1
2007high 1 (2017) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MXK

1in 2025

2010: 12013: 12017: 22018: 22019: 22020: 22024: 12025: 1
2007high 2 (2017) · low 0 (2007)2025

MAUDE reports naming product code MXK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20081—00
20090—00
20100—01
20110—00
20120—00
20130—01
20140—00
20151—00
20161—00
20170—12
20180—02
20192—02
20201—02
20211—00
20221—00
20231—00
20241—01
20251—01
20261—0—

What is it indicated for?

MYAH is intended for measuring the axial length of the eye in a population age 5 and above and is intended for use under the care of an eye care professional.

MYAH is not intended to be used in patients with cataracts.

Indications for use read by OCR from a scanned FDA 510(k) statement, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K211868: MYAH.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K211868

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026